Bupivacaine Recruiting Phase 4 Trials for Migraine Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03666663Sphenopalatine Ganglion Blocks RCT
NCT03159000A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks